510(k) K183160
K183160 is an FDA 510(k) premarket notification submitted by Haemonetics Corporation for the device "TEG 6s Hemostasis System, TEG 6s Citrated: K, RT, FF Assay Cartridge". The FDA issued a decision of Substantially Equivalent on May 9, 2019. The device falls under product code JPA (System, Multipurpose For In Vitro Coagulation Studies), a Class II device regulated under 21 CFR 864.5425. Haemonetics Corporation has at least 6 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 9, 2019
- Date Received
- November 15, 2018
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Multipurpose For In Vitro Coagulation Studies
- Device Class
- Class II
- Regulation Number
- 864.5425
- Review Panel
- HE
- Submission Type